CSL Partners With Amazon Web Services to Deploy AI in Drug Development

Australia's CSL has entered into a strategic collaboration with Amazon Web Services to integrate artificial intelligence and cloud computing infrastructure across its research and clinical development pipeline. Under the agreement, CSL scientists will deploy AWS tools to analyze scientific data, identify viable drug targets earlier, and link laboratory wet-lab research with computational predictive modeling. The partnership will also automate clinical administrative tasks, including protocol drafting, trial data management, and regulatory submissions. Following the announcement, CSL shares traded largely unchanged at A$181.9.